Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral drug resistance and routine therapy, Cameroon.

Emerging infectious diseases - 1 Jun 2006

Laurent Christian, Kouanfack Charles, Vergne Laurence, Tardy Michèle, Zekeng Léopold, Noumsi Nathalie, Butel Christelle, Bourgeois Anke, Mpoudi-Ngolé Eitel, Koulla-Shiro Sinata, Peeters Martine, Delaporte Eric

Abstract excerpt

Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Cameroon

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Serotyping

Share to Urban Population

Source

Open in PubMed Open full text

Identifiers

PMID: 16707062
DOI: 10.3201/eid1206.050860
PMCID: PMC3298273

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiretroviral drug resistance and routine therapy, Cameroon.PMID 16707062Read ↗

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.Semantic proximity Read ↗

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity Read ↗

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.Semantic proximity Read ↗

Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in CameroonSemantic proximity Read ↗

Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.Semantic proximity Read ↗

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.Semantic proximity Read ↗

Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.Semantic proximity Read ↗

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.Semantic proximity Read ↗

Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon.Semantic proximity Read ↗

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.Semantic proximity Read ↗

Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low- or high-level viraemiaSemantic proximity Read ↗

[Effects of prolonged exposure to antiretroviral treatment in Tunisian patients assessed by the HIV-1 resistance genotypic test].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.